| Akoya Biosciences–SEVERAL: investment, 202306 public offering up to $43.5m+$6.525m with 8.7m+1.305m shares common stock at $5/share |
2023-06-08 |
| Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform |
2023-06-05 |
| Midwest Biosolutions–Bionter: analytical instruments, 202305– collab Midwest Bio to promote + sell Bionter products + services in the US |
2023-05-08 |
| Zontal–Bruker: investment, 202305 acquisition $14.8m of Zontal by Bruker |
2023-05-08 |
| Ten23 Health–Bionter: particle counting, 202305– collab developm of methods incl installation of EVE particle counter at Ten23 Heatlh |
2023-05-02 |
| Bio-Techne–Lunaphore: spatial omics, 202304– collab strategic partnership integrating COMET system with RNAscope technology |
2023-04-17 |
| Mérieux–Oxford Nanopore: nanopore technology, 202304– collab strategic exploring nanopore sequencing for infectious disease diagnostics bioMérieux |
2023-04-14 |
| Pinpoint Testing–Bruker: investment, 202303 acquisition $8.6m of Pinpoint Testing LLC by Bruker |
2023-03-28 |
| Agilent–Hamamatsu: digital pathology, 202303– collab distribution of NanoZoomer digital pathology slide scanners by Agilent |
2023-03-10 |
| Agilent–e-MSion: mass spectrometry technology, 2019– collab co-marketing of ExD cell technology with 6500 Series LC-/Q-TOF |
2023-03-09 |
| e-MSion–Agilent: investment, 202303 acquisition of e-MSion by Agilent |
2023-03-09 |
| Agilent–Proscia: digital pathology, 202303– collab ww distribution multi-year for Concentriq Dx platform with Agilent digital pathology solutions |
2023-03-08 |
| Fasmatech–Bruker: investment, 202303 acquisition $10.3m of Fasmatech by Bruker |
2023-03-03 |
| Astrea Bioseparations–Biotage: investment, 202302– acquisition $190m in shares + $45 cash milestones of Astrea from Gamma Biosciences (KKR) |
2023-02-15 |
| Biotage–KKR: investment, 202302– investment $25m tog with sale of Astrea Bioseparations by Gamma for shares resulting in 17% share in Biotage of Gamma |
2023-02-15 |
| Wyatt Technology–Waters: investment, 202302–202305 acquisition $1.36b in cash of Wyatt by Waters |
2023-02-15 |
| HEL Group–Zyme Communications: public relations, 202302 service existent by Zyme |
2023-02-08 |
| Danaher–Seed Biosciences: cell dispenser, 202302– distribution excl of DinspenCell in US + Asia + resale in Europe by Molecular Devices |
2023-02-07 |
| SAMDI Tech–Charles River: investment, 202301 acquisition of remaining 80% not already owned for $50m in cash by Charles River |
2023-01-30 |
| Agilent–Plasmion: ionisation technology, 202301– collab co-marketing of SICRIT ion source with Agilent Ultivo LC/TQ + LC/MSD iQ MS systems |
2023-01-18 |
| Siemens–ASG Superconductors: magnetic resonance imaging, 202301– collab integration of ASG MRI magnets >7T in Siemens Healthineers UFH MRI systems |
2023-01-18 |
| InDevR–Adjuvant Capital: investment, 202301 financing round Series B totalling $9m incl $4m from Adjuvant Capital |
2023-01-17 |
| InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership |
2023-01-17 |
| InDevR–SEVERAL: investment, 202301 financing round Series B $9m from bioMérieux + Adjuvant Capital |
2023-01-17 |
| Mérieux–InDevR: VaxArray platform, 202301– excl distribution of VaxArray portfolio by bioMérieux in Europe |
2023-01-17 |
| Delta Precision–Astrea Bioseparations: investment, 202301 acquisition of Delta Precision Ltd by Astrea |
2023-01-09 |
| Evosep–Novo Group: investment, 202301 minority investment of $40m by Novo Holdings A/S |
2023-01-09 |
| Acquifer Imaging–Bruker: investment, 202301 acquisition $7.6m of Acquifer Imaging Gmbh + subsidiary Deltabyte GmbH by Bruker |
2023-01-05 |
| Biognosys–Bruker: investment, 202301 acquisition $73.6m of majority share in Biognosys by Bruker |
2023-01-04 |
| Danaher–Advanced Solutions: laboratory automation equipment, 202301 collab developm BAB400 with ImageXpress for 3D Cell Culture + sales by MolDev |
2023-01-04 |
| Tescan–Carlyle: investment, 202301 acquisition of Tescan by Carlyle |
2023-01-01 |
| IsoPlexis–Berkeley Lights: investment, 202212–202303 merger acquisition $57.8m in shares with former Berkeley owners holding 75.2%, renamed PhenomeX |
2022-12-21 |
| Numares–EU (govt): credit, 202212– quasi-equity venture debt financing up to €20m from EIB |
2022-12-20 |
| Numares–SEVERAL: investment, 202212 financing round €20m from existing investors |
2022-12-20 |
| Variolytics–SEVERAL: investment, 202212 seed financing round €7-digit from HTGF + FTTF + business angels |
2022-12-07 |
| Cellesce–Danaher: investment, 202212 acquisition of Cellesce by Molecular Devices |
2022-12-06 |
| Neurescence–Bruker: investment, 202211–202212 acquisition 100% of Neurescence Inc by Bruker |
2022-11-14 |
| Elemental Machines–SEVERAL: investment, 202211 financing round Series B $41m led by Sageview Capital |
2022-11-10 |
| Inscopix–Bruker: investment, 202211 acquisition $101.5m of Inscopix by Bruker |
2022-11-08 |
| Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED |
2022-10-31 |
| MS-Omics–Clinical Microbiomics: investment, 202210 acquisition of MS-Omics ApS by Clinical Microbiomics A/S |
2022-10-17 |
| Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva |
2022-10-06 |
| Irubis–EU (govt): investment, 202210 seed financing round totalling €2.8m incl co-investor EIC Fund |
2022-10-06 |
| Irubis–High-Tech Gründerfonds: investment, 202210 seed financing round totalling €2.8m incl co-lead investor HTGF |
2022-10-06 |
| Irubis–OTHER: investment, 202210 seed financing round totalling €2.8m incl business angels as co-investors |
2022-10-06 |
| Irubis–SEVERAL: investment, 202210 seed financing round €2.8m led by HTGF + Verve Ventures + Ventura BioMed Investors |
2022-10-06 |
| Irubis–TU Munich: investment, 202210 seed financing round totalling €2.8m incl co-investor Initiative for Industrial Innovators |
2022-10-06 |
| Irubis–Ventura Biomed Investors: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Ventura Biomed Investors |
2022-10-06 |
| Irubis–Verve Capital Partners: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Verve Ventures |
2022-10-06 |
| Agilent–Scitara: lab informatics, 202209– collab product integration of OpenLab CDS + SLIMS with Scientific Integration Platform SIP + DLX |
2022-09-21 |
| ValitaCell–Danaher: investment, 202209 acquisition of ValitaCell by Beckman Coulter Life Sciences |
2022-09-13 |
| 2bind–Dynamic Biosensors: switchSENSE technology, 202209– collab technology-service with 2bind using HeliX biosensor system as certified beta customer |
2022-09-01 |
| Agilent–Bright Giant: mass spectrometry software, 202208– collab developm s/w for AI-based small-molecule identification in mass spec metabolomics |
2022-08-16 |
| Parsum–Sopat: investment, 202208 acquisition of Parsum GmbH by Sopat GmbH with its investor WZ Process BV |
2022-08-12 |
| Trace Analytics–908 Devices: investment, 202208 acquisition $15.3m upfront cash + $2m cash milestones |
2022-08-09 |
| Atlas Antibodies–Genovis: MS-based analysis of biopharmaceuticals, 202208– supply service LC-MS analytics of recombinant CHO-antibodies to Evitria |
2022-08-08 |
| Polymer Standards Service–Agilent: investment, 202208 acquisition €na of PSS by Agilent |
2022-08-02 |
| NeoSphere Biotechnologies–SEVERAL: investment, 202207 financing round Series A €6m |
2022-07-25 |
| Namocell–Bio-Techne: investment, 202206–202207 acquisition $101.2m of Namocell by Bio-Techne |
2022-06-22 |
| SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures |
2022-06-22 |
| ModuVision–Knauer: investment, 202206 acquisition of ModuVision by Knauer |
2022-06-13 |
| Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners |
2022-06-09 |
| Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital |
2022-06-09 |
| Peptone–Hoxton Ventures: investment, 202206 financing round Series A totalling $40m incl existing + co-investor Hoxton Ventures |
2022-06-09 |
| Peptone–Novartis: investment, 202206 financing round Series A totalling $40m incl existing + co-investor dRX Capital |
2022-06-09 |
| Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine |
2022-06-09 |
| Peptone–SEVERAL: investment, 202206 financing round Series A $40m led by F-Prime + Bessemer Venture Partners |
2022-06-09 |
| Peptone–Walden Catalyst: investment, 202206 financing round Series A totalling $40m incl co-investor Walden Catalyst Vemtures |
2022-06-09 |
| Agilent–Mettler-Toledo: lab automation, –202206 collab developm + product integration automated + digitalised sample prep for LC/GC workflow |
2022-06-01 |
| CatSci–Keensight Capital: investment, 202206 investment by Keensight Capital to support expansion |
2022-06-01 |
| Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD |
2022-06-01 |
| Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance |
2022-06-01 |
| Irubis–EU (govt): grant, 202005– grant €1.3m from EIC Accelerator Pilot Programme |
2022-05-26 |
| Bruker–TOFwerk: time-of-flight mass spectrometry, 2022205– collab strategic partnership for applied + industrial markets |
2022-05-10 |
| TOFwerk–Bruker: investment, 202205 minority investment in TOFwerk by Bruker |
2022-05-10 |
| OMass–Consilium: public relations, 202204 service existent by Consilium Strategic Communications |
2022-04-28 |
| OMass–SEVERAL: investment, 202204 financing round Series B £75.5m led by new investors GV + Northpond Ventures + Sanofi Ventures |
2022-04-28 |
| Debiopharm–Dotmatics: data integration + analysis s/w, 202204 supply existent Debiopharm is customer of Dotmatics |
2022-04-26 |
| Peak Proteins–Sygnature Discovery: investment, 202204 acquisition €na of Peak Proteins by Sygnature Discovery |
2022-04-26 |
| PerkinElmer–Scitara: lab informatics, 202204– collab product integration of Signals informatics platform with Scientific Integration Platform SIP |
2022-04-14 |
| Refeyn–Foresight Group: investment, 202204 financing round Series B incl existing + co-investor Foresight Group |
2022-04-11 |
| Refeyn–Horizons Ventures: investment, 202204 financing round Series B incl existing + co-investor Horizons Ventures |
2022-04-11 |
| Refeyn–Northpond Ventures: investment, 202204 financing round Series B incl lead investor Northpond Ventures |
2022-04-11 |
| Refeyn–Oxford Science Enterprises: investment, 202204 financing round Series B incl existing + co-investor OSE |
2022-04-11 |
| Refeyn–SEVERAL: investment, 202204 financing round Series B led by Northpond Ventures |
2022-04-11 |
| Refeyn–Univ Oxford: investment, 202204 financing round Series B incl existing + co-investor Univ Oxford |
2022-04-11 |
| Enable Medicine–SEVERAL: investment, 202204 financing round Series A $60m led by Anthos Capital + General Catalyst |
2022-04-07 |
| IonSense–Bruker: investment, 202204 acquisition of IonSense by Bruker |
2022-04-06 |
| Optimal Industrial–Bruker: investment, 202204 acquisition $40.3m of Optimal Industrial Automation + Technologies by Bruker |
2022-04-05 |
| Irubis–EU (govt): credit, 202203– convertible loan €500k from EIC Fund as part of EIC Accelerator Pilot programme |
2022-03-24 |
| Biogenity–Denmark (govt): investment, 202203 Innovation Fund Denmark invests in Innobooster project BioSWITCH |
2022-03-23 |
| PrognomiQ–Bruker: investment, 202203 financing round totalling $46m incl lead investor Bruker Corp |
2022-03-15 |
| PrognomiQ–SEVERAL: investment, 202203 financing round $46m led by Bruker Corp |
2022-03-15 |
| Fluidigm–Casdin Capital: investment, 202201–202204 acquisition totalling $250m zero-coupon convertible preferred shares incl Casdin Capital |
2022-01-24 |
| Fluidigm–SEVERAL: investment, 202201–202204 acquisition $250m zero-coupon convertible preferred shares by Casdin Capital + Viking Global Investors |
2022-01-24 |
| Fluidigm–Viking Global Investors: investment, 202201–202204 acquisition totalling $250m zero-coupon convertible preferred shares incl Viking |
2022-01-24 |
| Prolab Instruments–Bruker: investment, 202201 acquisition €na of Prolab Instruments Gmbh by Bruker |
2022-01-19 |
| PreOmics–Bruker: investment, 202201 acquisition €na of shares of HTGF + Think.Health Ventures + certain business angels by Bruker |
2022-01-18 |
| PreOmics–Bruker: investment, 202201 Series B investment €13.5m from Bruker tog w secondary transaction making Bruker majority shareholder |
2022-01-18 |
| Omiq–Insightful Science: investment, 202201 acquisition of Omiq Inc by Insightful Science |
2022-01-13 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
1 2 3 4 5 6 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
